/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation
Event: EHRA 2022
Topic: Mechanisms for Heart Failure and Cardiac Complications
Session: ePosters Day 2
Soluble ST2 and renal function in ischemic heart failure with atrial fibrillation
Event: EHRA 2021
Topic: Arrhythmias
Session: ePoster session
Effects of statins on major adverse cardiovascular events in patients with ischemic chronic heart failure with reduced ejection fraction and renal dysfunction
Event: Heart Failure 2019
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
Independent predictors of sudden cardiac death in patients with ischemic chronic heart failure with preserved ejection fraction and renal dysfunction
Event: Heart Failure 2018
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
Effects of trimetazidine in patients with ischemic chronic heart failure with reduced ejection fraction and renal dysfunction
Event: EuroPrevent 2017
Topic: Sudden Cardiac Death
Session: Epidemiology/ Public health_Part 3
Echocardiographic predictors of worse outcome in patients with ischemic chronic heart failure and renal disfunction
Event: EuroEcho-Imaging 2016
Topic: Clinical applications
Session: Tissue Doppler and speckle tracking
Risk factors for renal function decline in patients with ischemic chronic heart failure
Event: EuroPRevent Meeting 2016
Topic: Risk factors and risk prediction
Session: Posters Group 7
Circadian blood pressure profile in patients with ischemic chronic heart failure with renal dysfunction
Event: HEART FAILURE 2016
Topic: Cardio-renal syndrome
Session: Co-morbidities
ESC 365 is supported by
